Voyager Therapeutics, Inc. (VYGR) Misled Shareholders Regarding the Viability of its Lead Clinical Candidate for Huntington’s Disease On June 1, 2017, Voyager Therapeutics, Inc. announced that it had selected
Voyager Therapeutics, Inc. (VYGR) Misled Shareholders Regarding the Viability of its Lead Clinical Candidate for Huntington’s Disease On June 1, 2017, Voyager Therapeutics, Inc. (VYGR) announced that it had
Decision Diagnostics Corp. (DECN) Misled Shareholders Regarding the Availability of its Blood Test to Detect COVID-19 According to the complaint, throughout the relevant period, defendants claimed that the Company
Lizhi Inc. (LIZI) Misled Shareholders Regarding the Impact of the Coronavirus on its Financial Condition and Prospects Lizhi sold more than 4.1 million American Depository Shares at $11.00 per
Lizhi Inc. (LIZI) Misled Shareholders Regarding the Impact of the Coronavirus on its Financial Condition and Prospects Lizhi sold more than 4.1 million American Depository Shares at $11.00 per
Decision Diagnostics Corp. (DECN) Misled Shareholders Regarding the Availability of its Blood Test to Detect COVID-19 According to the complaint, throughout the relevant period, defendants claimed that the Company
Are you a former employee of Nissan Motor Co., Ltd. (NSANY) (NSANF) (7201.T) and own stock in the company? Robbins LLP is investigating breaches of fiduciary duty by the officers
EQT Corporation (EQT) Allegedly Made False Statements About Its Acquisition of Rice Energy Inc. On June 19, 2017, EQT announced that it had entered into an agreement to acquire rival
Berry Corporation (BRY) Misled Shareholders about its Operational Efficiency and Stability Berry conducted its IPO on July 26, 2018, issuing 13 million shares of Berry common stock at $14
Attorney Advertising. Past results do not guarantee a similar outcome.
5060 Shoreham Pl., Ste. 300 San Diego, CA 92122
Disclaimer | Site Map | Privacy Policy
© 2024 – Robbins LLP
Protect yourStock Watch members receive free investment monitoring and notifications.
